Yi Ning

Dr. Yi Ning

orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2007 in Diagnostic Pathology
Verified
Journal Article
Open access
PDF file
BABorislav Alexandrov Alexiev
Borislav Alexandrov Alexiev
WWWenle Wang
Wenle Wang
YNYi Ning
Yi Ning
SCSaranya Chumsri
Saranya Chumsri
IGIvana Gojo
Ivana Gojo
XZXianfeng F Zhao
Xianfeng F Zhao
Myeloid sarcoma (MS) is a neoplasm of immature granulocytes, monocytes, or both involving any extramedullary site. The correct diagnosis of MS is important for adequate therapy, which is often delayed because of a high misdiagnosis rate. To evaluate the lineage differentiation of neoplastic cells in MS by immunohistochemistry, and to correlate the results with clinicopathologic findings and cytogenetic studies. Histologic and immunohistochemical examinations were performed on formalin-fixed paraffin-embedded tissue samples from 13 cases of MS. They were classified according to the World Health Organization criteria. Chromosomal analysis data were available in 11 cases. Clinical, pathological, and cytogenetic findings were analyzed. The study included six male and seven female patients with an age range of 25 to 72 years (mean, 49.3 years) and a male to female ratio of 1:1.2. MS de novo occurred in 4/13 (31%) of cases examined. The most sensitive immunohistochemical markers were CD43 and lysozyme present in all cases with MS (13/13, 100%). All de novo MS showed a normal karyotype, monoblastic differentiation, and lack of CD34. The most common chromosomal abnormalities in MS associated with a hematopoietic disorder were trisomy 8 and inv(16) (2/11, 18%). An immunohistochemical panel including CD43, lysozyme, myeloperoxidase (MPO), CD68 (or CD163), CD117, CD3 and CD20 can successfully identify the vast majority of MS variants in formalin-fixed paraffin-embedded tissue sections. The present report expands the spectrum of our knowledge showing that de novo MS has frequent monoblastic differentiation and frequently carries a normal karyotype.

25 September 1995 in American Journal of Medical Genetics
Verified
Journal Article
Closed access
PDF file
LBLeslie G. Biesecker
Leslie G. Biesecker
MRMarjorie Rosenberg
Marjorie Rosenberg
LDLaura Dziadzio
Laura Dziadzio
DLDavid H. Ledbetter
David H. Ledbetter
YNYi Ning
Yi Ning
KRKenneth Rosenbaum
Kenneth Rosenbaum

1 June 2003 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
YNYi Ning
Yi Ning
JXJing-Fan Xu
Jing-Fan Xu
YLYu Li
Yu Li
LCLiz Chavez
Liz Chavez
HRHarold C. Riethman
Harold C. Riethman
NWNan-Ping Weng
Nan-Ping Weng
Progressive telomere shortening occurs with division of normal human cells, and eventually leads to replicative senescence. The mechanism by which the shortened telomeres cause growth arrest is largely unknown. Transcriptional silencing of genes adjacent to telomeres, also called telomere position effect, has been hypothesized as a possible mechanism of telomere-mediated senescence. However, there is no report regarding telomere position effect on natural telomeric genes in human cells. To address whether the expression of natural telomeric genes is regulated by telomere length, we combined quantitative RT–PCR with quantitative fluorescence in situ hybridization to comparatively analyze the expression of 34 telomeric genes and telomere length of their 24 corresponding chromosome ends in young and senescent human fibroblasts. We have demonstrated here that telomere length alone is not sufficient to determine the expression status of natural telomeric genes. An extended analysis of a tandem of eight telomeric genes on a single chromosome end revealed a discontinuous pattern of changed expression during telomere shortening and some of the changes are senescence-specific rather than non-dividing-related. These results suggest that the expression of natural telomeric genes may be influenced by alteration of local heterochromatin structure.

29 September 2005 in Leukemia
Verified
Journal Article
Open access
PDF file
JCJ A Crowley
J A Crowley
YWY Wang
Y Wang
ARA P Rapoport
A P Rapoport
YNYi Ning
Yi Ning
Detection of MOZ-CBP fusion in acute myeloid leukemia with 8;16 translocation

20 December 2012 in Human Pathology
Verified
Journal Article
Closed access
YXYanfeng Xi
Yanfeng Xi
JLJing Li
Jing Li
LZLikun Zan
Likun Zan
JWJinfen Wang
Jinfen Wang
GWGuoping Wang
Guoping Wang
YNYi Ning
Yi Ning

16 August 2023 in Best Practice & Research Clinical Haematology
Verified
Journal Article
Closed access
YNYi Ning
Yi Ning
YZYanming Zhang
Yanming Zhang
MKMichael Kallen
Michael Kallen
AEAshkan Emadi
Ashkan Emadi
BRBaer M R
Baer M R